http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1298140-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4afb8b01aa8de7e0b24a86713b23a18 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1841 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1875 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate | 2002-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba29920c3e308f5807e99d8fe03b623 |
| publicationDate | 2003-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1298140-A2 |
| titleOfInvention | Mutants of bone morphogenetic proteins (BMP) |
| abstract | The present invention relates to novel mutants of bonenmorphogenetic proteins (BMPs) useful as inhibitors ofnheterotopic ossification. Specifically, the presentninvention relates to novel mutants containing only thenentire region involved in the formation of finger 2nincluding the wrist epitope of a BMP with a specificncysteine residue or specific cysteine residues replacednby a different amino acid. The present invention alsonrelates pharmaceutical compositions containing thesenmutants and to the use of the mutants andnpharmaceutical compositions in therapy. |
| priorityDate | 2001-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 226.